Latest news with #BlueJet
Time of India
22-07-2025
- Business
- Time of India
Blue Jet Healthcare shares crash 10% post Q1 earnings. Here's what triggered the fall
Blue Jet Healthcare shares: The company posted a 4% drop in June quarter revenue, recording ₹355 crore compared to ₹340 crore in the same quarter of the previous financial year. Tired of too many ads? Remove Ads Tired of too many ads? Remove Ads Shares of Blue Jet Healthcare tanked 10% on Tuesday to hit the day's low Rs 90.6.15 on the NSE following the announcement of its Q1 earnings. The company reported a 17% drop in its sequential net profit to Rs 91 crore versus Rs 110 crore reported in company also reported a 4% decline in its June quarter revenues at Rs 355 crore as against Rs 340 crore reported in the corresponding quarter of the last financial selling pressure was seen despite a 141% surge in Blue Jet's profit after tax (PAT) on a year-on-year basis with the company reporting a bottom line of Rs 38 crore in Q1FY25. The topline increased by 118% on the YoY basis versus Rs 163 crore posted in the April-June quarter of FY25. Blue Jet Healthcare shares hit a 52-week high of Rs 1,027.80 on company's PAT decline could be attributed to a double-digit rise in its quarterly expenses on a QoQ and YoY basis. Blue Jet reported expenses of Rs 240 crore in the quarter under review, up 17% from Rs 205 crore in Q4FY25 and 97% from Rs 122 crore in the year-ago period. The expenses were made under the heads like 'Cost of Materials Consumed', 'Employee Benefits Expense', and 'Finance Cost', among other company is engaged in the manufacturing of artificial sweetener, contrast media intermediate, pharma intermediate, and APIs used in pharmaceutical and healthcare Jet Healthcare is a smallcap stock with a market capitalization of Rs 15,718.57. The stock has been a multibagger with 116% returns over a 1-year period. This stock has rallied 57% on a year-to-date basis notwithstanding today's sharp is currently trading above its 50-day and 200-day simple moving averages (SMAs) of Rs 884 and Rs 705, respectively, according to Trendlyne. The stock has also displayed high volatility in the past one year with a beta of read: IRFC stock tumbles 35% after 551% 3-year surge. What to do ahead of Q1 results?
Economic Times
22-07-2025
- Business
- Economic Times
Blue Jet Healthcare shares crash 10% post Q1 earnings. Here's what triggered the fall
Live Events (You can now subscribe to our (You can now subscribe to our ETMarkets WhatsApp channel Shares of Blue Jet Healthcare tanked 10% on Tuesday to hit the day's low Rs 90.6.15 on the NSE following the announcement of its Q1 earnings. The company reported a 17% drop in its sequential net profit to Rs 91 crore versus Rs 110 crore reported in company also reported a 4% decline in its June quarter revenues at Rs 355 crore as against Rs 340 crore reported in the corresponding quarter of the last financial selling pressure was seen despite a 141% surge in Blue Jet's profit after tax (PAT) on a year-on-year basis with the company reporting a bottom line of Rs 38 crore in Q1FY25. The topline increased by 118% on the YoY basis versus Rs 163 crore posted in the April-June quarter of FY25. Blue Jet Healthcare shares hit a 52-week high of Rs 1,027.80 on company's PAT decline could be attributed to a double-digit rise in its quarterly expenses on a QoQ and YoY basis. Blue Jet reported expenses of Rs 240 crore in the quarter under review, up 17% from Rs 205 crore in Q4FY25 and 97% from Rs 122 crore in the year-ago period. The expenses were made under the heads like 'Cost of Materials Consumed', 'Employee Benefits Expense', and 'Finance Cost', among other company is engaged in the manufacturing of artificial sweetener, contrast media intermediate, pharma intermediate, and APIs used in pharmaceutical and healthcare Jet Healthcare is a smallcap stock with a market capitalization of Rs 15,718.57. The stock has been a multibagger with 116% returns over a 1-year period. This stock has rallied 57% on a year-to-date basis notwithstanding today's sharp is currently trading above its 50-day and 200-day simple moving averages (SMAs) of Rs 884 and Rs 705, respectively, according to Trendlyne. The stock has also displayed high volatility in the past one year with a beta of read: IRFC stock tumbles 35% after 551% 3-year surge. What to do ahead of Q1 results?
Business Standard
30-04-2025
- Business
- Business Standard
Blue Jet Healthcare jumps after broker initiates 'buy' rating
Shares of Blue Jet Healthcare rose 4% to Rs 713 after a domestic brokerage initiated coverage on the stock with a 'Buy' rating and a target price of Rs 865. The broker cited a favourable outlook supported by the company's ability to scale up high-margin products and secure more long-term contracts, which could potentially enhance both growth and valuations. The brokerage noted that Blue Jets advanced research and development capabilities, along with its backward integration and expertise in complex chemistries, position it well to serve both regulated and emerging markets. These factors, it said, place the company at the forefront of delivering high-value pharma solutions. Looking ahead, the brokerage expects Blue Jet's revenue growth to be fueled by its pipeline of new products in iodinated and gadolinium contrast media, novel chemical entity (NCE) intermediates, and innovations in high-intensity sweeteners. Blue Jet Healthcare is a specialty pharmaceutical and healthcare ingredient and intermediate company, operating under a contract development and manufacturing organization ("CDMO") business model. The company has specialized chemistry capabilities in contrast media intermediates and high-intensity sweeteners. On a standalone basis, net profit of Blue Jet Healthcare soared 208.25% to Rs 98.98 crore while net sales climbed 90.92% to Rs 318.38 crore in Q3 December 2024 over Q3 December 2023.
